{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:46:13Z","timestamp":1793969173563,"version":"4.8.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018R1A5A2025964"],"award-info":[{"award-number":["NRF-2018R1A5A2025964"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CNMPB"],"award-info":[{"award-number":["CNMPB"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Parkinson\u2019s disease (PD) and Multiple System Atrophy (MSA) are clinically distinctive diseases that feature a common neuropathological hallmark of aggregated \u03b1-synuclein. Little is known about\u00a0how differences in \u03b1-synuclein aggregate structure affect disease phenotype. Here, we amplified \u03b1-synuclein aggregates from PD and MSA brain extracts and analyzed the conformational properties using fluorescent probes, NMR spectroscopy and electron paramagnetic resonance. We also generated and analyzed several in vitro \u03b1-synuclein polymorphs. We found that brain-derived \u03b1-synuclein fibrils were structurally different to all of the in vitro polymorphs analyzed. Importantly, there was a greater structural heterogeneity among \u03b1-synuclein fibrils from the\u00a0PD brain compared to those from the\u00a0MSA brain, possibly reflecting on the greater variability of disease phenotypes evident in PD. Our findings have significant ramifications for the use of non-brain-derived \u03b1-synuclein fibrils in PD and MSA studies, and raise important questions regarding the\n                    <jats:italic>one disease-one strain<\/jats:italic>\n                    hypothesis in the study of \u03b1-synucleinopathies.\n                  <\/jats:p>","DOI":"10.1038\/s41467-019-13564-w","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T06:03:29Z","timestamp":1575439409000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":220,"title":["Structural heterogeneity of \u03b1-synuclein fibrils amplified from patient brain extracts"],"prefix":"10.1038","volume":"10","author":[{"given":"Timo","family":"Stroh\u00e4ker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Chul","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9716-6108","authenticated-orcid":false,"given":"Shu-Hao","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio O.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2041-5740","authenticated-orcid":false,"given":"Stefan","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0422-8398","authenticated-orcid":false,"given":"Glenda M.","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Bennati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4707-933X","authenticated-orcid":false,"given":"Woojin S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2536-6581","authenticated-orcid":false,"given":"Markus","family":"Zweckstetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,4]]},"reference":[{"key":"13564_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1146\/annurev-genet-120215-034943","volume":"50","author":"LC Walker","year":"2016","unstructured":"Walker, L. C. Proteopathic strains and the heterogeneity of neurodegenerative diseases. Annu Rev. Genet 50, 329\u2013346 (2016).","journal-title":"Annu Rev. Genet"},{"key":"13564_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/B978-0-12-802395-2.00024-9","volume":"145","author":"I Alafuzoff","year":"2017","unstructured":"Alafuzoff, I. & Hartikainen, P. Alpha-synucleinopathies. Handb. Clin. Neurol. 145, 339\u2013353 (2017).","journal-title":"Handb. Clin. Neurol."},{"key":"13564_CR3","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","volume":"557","author":"C Peng","year":"2018","unstructured":"Peng, C. et al. Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies. Nature 557, 558\u2013563 (2018).","journal-title":"Nature"},{"key":"13564_CR4","doi-asserted-by":"publisher","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","volume":"112","author":"SB Prusiner","year":"2015","unstructured":"Prusiner, S. B. et al. Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc. Natl Acad. Sci. USA 112, E5308\u2013E5317 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"13564_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3575","volume":"4","author":"L Bousset","year":"2013","unstructured":"Bousset, L. et al. Structural and functional characterization of two alpha-synuclein strains. Nat. Commun. 4, 2575 (2013).","journal-title":"Nat. Commun."},{"key":"13564_CR6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature14547","volume":"522","author":"W Peelaerts","year":"2015","unstructured":"Peelaerts, W. et al. Alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522, 340\u2013344 (2015).","journal-title":"Nature"},{"key":"13564_CR7","doi-asserted-by":"crossref","unstructured":"Guerrero-Ferreira, R. et al. Cryo-EM structure of alpha-synuclein fibrils. Elife 7, e36402 (2018).","DOI":"10.7554\/eLife.36402"},{"key":"13564_CR8","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41422-018-0075-x","volume":"28","author":"Y Li","year":"2018","unstructured":"Li, Y. et al. Amyloid fibril structure of alpha-synuclein determined by cryo-electron microscopy. Cell Res. 28, 897\u2013903 (2018).","journal-title":"Cell Res."},{"key":"13564_CR9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nsmb.3194","volume":"23","author":"MD Tuttle","year":"2016","unstructured":"Tuttle, M. D. et al. Solid-state NMR structure of a pathogenic fibril of full-length human alpha-synuclein. Nat. Struct. Mol. Biol. 23, 409\u2013415 (2016).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"13564_CR10","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/35081095","volume":"411","author":"GP Saborio","year":"2001","unstructured":"Saborio, G. P., Permanne, B. & Soto, C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810\u2013813 (2001).","journal-title":"Nature"},{"key":"13564_CR11","doi-asserted-by":"crossref","unstructured":"Nicot, S. et al. Seeded propagation of alpha-synuclein aggregation in mouse brain using protein misfolding cyclic amplification. FASEB J 33, 12073\u201312086 (2019).","DOI":"10.1096\/fj.201900354R"},{"key":"13564_CR12","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/nm1286","volume":"11","author":"J Castilla","year":"2005","unstructured":"Castilla, J., Saa, P. & Soto, C. Detection of prions in blood. Nat. Med. 11, 982\u2013985 (2005).","journal-title":"Nat. Med."},{"key":"13564_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","volume":"74","author":"M Shahnawaz","year":"2017","unstructured":"Shahnawaz, M. et al. Development of a biochemical diagnosis of Parkinson disease by detection of alpha-synuclein misfolded aggregates in cerebrospinal fluid. JAMA Neurol. 74, 163\u2013172 (2017).","journal-title":"JAMA Neurol."},{"key":"13564_CR14","doi-asserted-by":"publisher","first-page":"11897","DOI":"10.1074\/jbc.M113.542340","volume":"289","author":"ME Herva","year":"2014","unstructured":"Herva, M. E. et al. Anti-amyloid compounds inhibit alpha-synuclein aggregation induced by protein misfolding cyclic amplification (PMCA). J. Biol. Chem. 289, 11897\u201311905 (2014).","journal-title":"J. Biol. Chem."},{"key":"13564_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.1","volume":"49","author":"BC Jung","year":"2017","unstructured":"Jung, B. C. et al. Amplification of distinct alpha-synuclein fibril conformers through protein misfolding cyclic amplification. Exp. Mol. Med 49, e314 (2017).","journal-title":"Exp. Mol. Med"},{"key":"13564_CR16","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nmeth1131","volume":"4","author":"CJ Sigurdson","year":"2007","unstructured":"Sigurdson, C. J. et al. Prion strain discrimination using luminescent conjugated polymers. Nat. Methods 4, 1023\u20131030 (2007).","journal-title":"Nat. Methods"},{"key":"13564_CR17","doi-asserted-by":"publisher","first-page":"E782","DOI":"10.1073\/pnas.1714966115","volume":"115","author":"C Condello","year":"2018","unstructured":"Condello, C. et al. Structural heterogeneity and intersubject variability of Abeta in familial and sporadic Alzheimer\u2019s disease. Proc. Natl Acad. Sci. USA 115, E782\u2013E791 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"13564_CR18","doi-asserted-by":"publisher","first-page":"10179","DOI":"10.1002\/chem.201301463","volume":"19","author":"T Klingstedt","year":"2013","unstructured":"Klingstedt, T. et al. The structural basis for optimal performance of oligothiophene-based fluorescent amyloid ligands: conformational flexibility is essential for spectral assignment of a diversity of protein aggregates. Chemistry 19, 10179\u201310192 (2013).","journal-title":"Chemistry"},{"key":"13564_CR19","doi-asserted-by":"publisher","first-page":"9072","DOI":"10.1002\/chem.201500556","volume":"21","author":"T Klingstedt","year":"2015","unstructured":"Klingstedt, T. et al. Distinct spacing between anionic groups: an essential chemical determinant for achieving thiophene-based ligands to distinguish beta-amyloid or tau polymorphic aggregates. Chemistry 21, 9072\u20139082 (2015).","journal-title":"Chemistry"},{"key":"13564_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ejmech.2004.02.013","volume":"39","author":"K Sato","year":"2004","unstructured":"Sato, K., Higuchi, M., Iwata, N., Saido, T. C. & Sasamoto, K. Fluoro-substituted and 13C-labeled styrylbenzene derivatives for detecting brain amyloid plaques. Eur. J. Med Chem. 39, 573\u2013578 (2004).","journal-title":"Eur. J. Med Chem."},{"key":"13564_CR21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/pro.570","volume":"20","author":"MK Cho","year":"2011","unstructured":"Cho, M. K., Kim, H. Y., Fernandez, C. O., Becker, S. & Zweckstetter, M. Conserved core of amyloid fibrils of wild type and A30P mutant alpha-synuclein. Protein Sci. 20, 387\u2013395 (2011).","journal-title":"Protein Sci."},{"key":"13564_CR22","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nsb792","volume":"9","author":"M Hoshino","year":"2002","unstructured":"Hoshino, M. et al. Mapping the core of the beta(2)-microglobulin amyloid fibril by H\/D exchange. Nat. Struct. Biol. 9, 332\u2013336 (2002).","journal-title":"Nat. Struct. Biol."},{"key":"13564_CR23","doi-asserted-by":"publisher","first-page":"8637","DOI":"10.1073\/pnas.0712179105","volume":"105","author":"M Vilar","year":"2008","unstructured":"Vilar, M. et al. The fold of alpha-synuclein fibrils. Proc. Natl Acad. Sci. USA 105, 8637\u20138642 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"13564_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05971-2","volume":"9","author":"B Li","year":"2018","unstructured":"Li, B. et al. Cryo-EM of full-length alpha-synuclein reveals fibril polymorphs with a common structural kernel. Nat. Commun. 9, 3609 (2018).","journal-title":"Nat. Commun."},{"key":"13564_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ymeth.2004.03.005","volume":"34","author":"MM Krishna","year":"2004","unstructured":"Krishna, M. M., Hoang, L., Lin, Y. & Englander, S. W. Hydrogen exchange methods to study protein folding. Methods 34, 51\u201364 (2004).","journal-title":"Methods"},{"key":"13564_CR26","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nature15368","volume":"525","author":"JA Rodriguez","year":"2015","unstructured":"Rodriguez, J. A. et al. Structure of the toxic core of alpha-synuclein from invisible crystals. Nature 525, 486\u2013490 (2015).","journal-title":"Nature"},{"key":"13564_CR27","doi-asserted-by":"publisher","first-page":"10290","DOI":"10.1002\/anie.201304747","volume":"52","author":"S Pornsuwan","year":"2013","unstructured":"Pornsuwan, S. et al. Long-range distances in amyloid fibrils of alpha-synuclein from PELDOR spectroscopy. Angew. Chem. Int Ed. Engl. 52, 10290\u201310294 (2013).","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"13564_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","volume":"251","author":"MG Spillantini","year":"1998","unstructured":"Spillantini, M. G. et al. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson\u2019s disease and dementia with Lewy bodies. Neurosci. Lett. 251, 205\u2013208 (1998).","journal-title":"Neurosci. Lett."},{"key":"13564_CR29","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. & Goedert, M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with lewy bodies. Proc. Natl Acad. Sci. USA 95, 6469\u20136473 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"13564_CR30","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature20814","volume":"541","author":"W Qiang","year":"2017","unstructured":"Qiang, W., Yau, W. M., Lu, J. X., Collinge, J. & Tycko, R. Structural variation in amyloid-beta fibrils from Alzheimer\u2019s disease clinical subtypes. Nature 541, 217\u2013221 (2017).","journal-title":"Nature"},{"key":"13564_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature23002","volume":"547","author":"AWP Fitzpatrick","year":"2017","unstructured":"Fitzpatrick, A. W. P. et al. Cryo-EM structures of tau filaments from Alzheimer\u2019s disease. Nature 547, 185\u2013190 (2017).","journal-title":"Nature"},{"key":"13564_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-018-0454-y","volume":"561","author":"B Falcon","year":"2018","unstructured":"Falcon, B. et al. Structures of filaments from Pick\u2019s disease reveal a novel tau protein fold. Nature 561, 137\u2013140 (2018).","journal-title":"Nature"},{"key":"13564_CR33","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41586-019-1026-5","volume":"568","author":"B Falcon","year":"2019","unstructured":"Falcon, B. et al. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature 568, 420\u2013423 (2019).","journal-title":"Nature"},{"key":"13564_CR34","doi-asserted-by":"publisher","first-page":"e43584","DOI":"10.7554\/eLife.43584","volume":"8","author":"W Zhang","year":"2019","unstructured":"Zhang, W. et al. Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer\u2019s and Pick\u2019s diseases. Elife 8, e43584 (2019).","journal-title":"Elife"},{"key":"13564_CR35","doi-asserted-by":"publisher","first-page":"19213","DOI":"10.1074\/jbc.M110551200","volume":"277","author":"H Miake","year":"2002","unstructured":"Miake, H., Mizusawa, H., Iwatsubo, T. & Hasegawa, M. Biochemical characterization of the core structure of alpha-synuclein filaments. J. Biol. Chem. 277, 19213\u201319219 (2002).","journal-title":"J. Biol. Chem."},{"key":"13564_CR36","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/ana.25446","volume":"85","author":"N Candelise","year":"2019","unstructured":"Candelise, N. et al. Seeding variability of different alpha synuclein strains in synucleinopathies. Ann. Neurol. 85, 691\u2013703 (2019).","journal-title":"Ann. Neurol."},{"key":"13564_CR37","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian, S. H. et al. Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nat. Neurosci. 22, 1099\u20131109 (2019).","journal-title":"Nat. Neurosci."},{"key":"13564_CR38","doi-asserted-by":"publisher","first-page":"e15801","DOI":"10.1371\/journal.pone.0015801","volume":"5","author":"M Johnson","year":"2010","unstructured":"Johnson, M., Coulton, A. T., Geeves, M. A. & Mulvihill, D. P. Targeted amino-terminal acetylation of recombinant proteins in E. coli. PLoS ONE 5, e15801 (2010).","journal-title":"PLoS ONE"},{"key":"13564_CR39","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1073\/pnas.0407146102","volume":"102","author":"CW Bertoncini","year":"2005","unstructured":"Bertoncini, C. W. et al. Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein. Proc. Natl Acad. Sci. USA 102, 1430\u20131435 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"13564_CR40","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0022-2836(02)00775-1","volume":"322","author":"W Hoyer","year":"2002","unstructured":"Hoyer, W. et al. Dependence of alpha-synuclein aggregate morphology on solution conditions. J. Mol. Biol. 322, 383\u2013393 (2002).","journal-title":"J. Mol. Biol."},{"key":"13564_CR41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0076-6879(92)10010-B","volume":"210","author":"ER Henry","year":"1992","unstructured":"Henry, E. R. & Hofrichter, J. Singular value decomposition: application to analysis of experimental data. Methods Enzymol. 210, 129\u2013192 (1992).","journal-title":"Methods Enzymol."},{"key":"13564_CR42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/BF00197809","volume":"6","author":"F Delaglio","year":"1995","unstructured":"Delaglio, F. et al. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277\u2013293 (1995).","journal-title":"J. Biomol. NMR"},{"key":"13564_CR43","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S0959-440X(94)90173-2","volume":"4","author":"A Bax","year":"1994","unstructured":"Bax, A. Multidimensional nuclear-magnetic-resonance methods for protein studies. Curr. Opin. Struc Biol. 4, 738\u2013744 (1994).","journal-title":"Curr. Opin. Struc Biol."},{"key":"13564_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pnmrs.2014.09.002","volume":"83","author":"M Mobli","year":"2014","unstructured":"Mobli, M. & Hoch, J. C. Nonuniform sampling and non-Fourier signal processing methods in multidimensional NMR. Prog. Nucl. Magn. Reson Spectrosc. 83, 21\u201341 (2014).","journal-title":"Prog. Nucl. Magn. Reson Spectrosc."},{"key":"13564_CR45","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jmr.2005.08.013","volume":"178","author":"S Stoll","year":"2006","unstructured":"Stoll, S. & Schweiger, A. EasySpin, a comprehensive software package for spectral simulation and analysis in EPR. J. Magn. Reson 178, 42\u201355 (2006).","journal-title":"J. Magn. Reson"},{"key":"13564_CR46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.pnmrs.2013.03.001","volume":"72","author":"G Jeschke","year":"2013","unstructured":"Jeschke, G. Conformational dynamics and distribution of nitroxide spin labels. Prog. Nucl. Magn. Reson. Spectrosc. 72, 42\u201360 (2013).","journal-title":"Prog. Nucl. Magn. Reson. Spectrosc."},{"key":"13564_CR47","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1006\/jmre.1999.1944","volume":"142","author":"M Pannier","year":"2000","unstructured":"Pannier, M., Veit, S., Godt, A., Jeschke, G. & Spiess, H. W. Dead-time free measurement of dipole-dipole interactions between electron spins. J. Magn. Reson. 142, 331\u2013340 (2000).","journal-title":"J. Magn. Reson."},{"key":"13564_CR48","doi-asserted-by":"publisher","first-page":"eaat5218","DOI":"10.1126\/sciadv.aat5218","volume":"4","author":"SG Worswick","year":"2018","unstructured":"Worswick, S. G., Spencer, J. A., Jeschke, G. & Kuprov, I. Deep neural network processing of DEER data. Sci. Adv. 4, eaat5218 (2018).","journal-title":"Sci. Adv."},{"key":"13564_CR49","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/BF03166213","volume":"30","author":"G Jeschke","year":"2006","unstructured":"Jeschke, G. et al. DeerAnalysis2006\u2014a comprehensive software package for analyzing pulsed ELDOR data. Appl Magn. Reson 30, 473\u2013498 (2006).","journal-title":"Appl Magn. Reson"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13564-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13564-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13564-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T21:21:19Z","timestamp":1671225679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13564-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,4]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["13564"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-13564-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,4]]},"assertion":[{"value":"17 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.-J.L. is a founder and co-CEO of Neuramedy Co., Ltd. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5535"}}